at a large tertiary care hospital and 690 randomly selected control patients. Logistic regression was used to identify fall risk factors.
F alls are common adverse events in hospitals and can result in significant injuries. Reported fall rates for hospital inpatients range from 1.7 to 25 falls per 1000 patient days, depending on the patient care area, with 6% to 44% resulting in injury. 1 Injurious falls are associated with increased health care costs, longer hospital stays, and greater likelihood of discharge to a nursing home or rehabilitation facility. 2, 3 Medication review has been recommended as part of multifaceted fall prevention programs for hospital inpatients. 4, 5 However, guidelines for how to assess medication risk or specifying which medications should be targeted are limited. Several medications have been reported to increase the risk for falling in the hospital, most commonly sedatives/hypnotics, benzodiazepines, and psychotropics. [6] [7] [8] Other medications, including antiepileptics, anticholinergics, β-blockers, and antidiabetic agents, have been inconsistently associated with fall risk. 6, 9 Although prior studies have evaluated medications as risk factors of falling, most have focused on broad medication classes rather than specific types of drugs, and few studies have evaluated the effect of newly prescribed versus long-term medications on fall risk. This lack of detail makes it difficult to develop an effective, comprehensive, and predictive view of a patient's fall risk and hinders the development of medication review interventions, which are a recommended part of comprehensive fall prevention strategies.
To provide more detailed information about the association between medications and falling in the hospital, we conducted a case-control study of patients who fell at a large teaching hospital. The objectives of this study were to identify specific medications and patient demographic and health characteristics associated with falls and to evaluate the impact of multiple high-risk medications and newly prescribed medications on fall risk.
METHODS

Study Population
This study was conducted at Barnes-Jewish Hospital (BJH), a 1074-bed urban tertiary care hospital affiliated with Washington University School of Medicine. In 2007, BJH had 1036 reported falls and a fall rate of 3.50 per 1000 patient days. The study included all inpatient falls reported to the hospital's safety event reporting system between June 29 and November 14, 2007 .
The BJH safety event reporting system defines a fall as a sudden and unplanned descent from a standing, sitting, or horizontal position to the floor or an extension of the floor. This definition includes falls related to physiologic events and falls in which the patient is assisted to the floor by staff or a visitor. Inpatients 21 years or older admitted to medicine, surgery, step-down, and critical care services were eligible for inclusion in this study. Patients in the emergency department or on the obstetrics service were excluded because risk factors of falls in these units differ from risk factors of falls among the general hospital population. Oncology and psychiatry patients were excluded because of their unique comorbidities and medications that may impact fall risk. Falls that occurred during physical therapy sessions were excluded because these sessions encourage activities that can cause postural instability and may result in the patient being lowered to the floor by a physical therapist to prevent injury.
Two hundred fifty fall events were prospectively identified for inclusion in the study using fall safety event reports. Fall reports were cross-referenced to identify patients who fell multiple times during their admission; only the first falls were included in the analysis. 10 For each patient who fell, 3 control patients who were in the hospital during the same period but did not fall were identified using the hospital's informatics database. Controls were randomly selected from patients who were admitted within 3 days of the index case and discharged after the date of the fall. For 6 cases with particularly long admissions, controls meeting these criteria could not be identified and patients admitted more than 3 days after the case patient were selected.
The study protocol was reviewed and approved by the Washington University Human Research Protection Office. The need for written informed consent was waived because the study used preexisting data and posed no additional risk to patients.
Data Sources
Patient demographic data, including age, sex, and body mass index (BMI), were obtained from the hospital informatics database. Data on history of falls; mobility; ability to estimate the time (a measure of confusion); whether the patient overestimated his/her abilities (based on nurse observations); urinary/stool frequency or incontinence; and presence of neuropathy, syncope/ fainting, or dizziness/orthostatic hypotension before the fall were abstracted from electronic medical records. Details about fall events, including fall location, whether the fall was assisted, and any resulting injuries, were collected from fall safety event reports. Data on all active medication orders from the 4 days before the fall were obtained from the hospital pharmacy database. Medications taken before admission were identified by comparing hospital drug orders with a list of home medications recorded in the patient's admission assessment according to the Joint Commission's medication reconciliation guidance for hospitals. Medications were considered "new" if first prescribed during the hospitalization and "continued" if taken before admission.
Statistical Analysis
Data abstracted from patient medical records were double entered into Microsoft Access (Redmond, WA), cleaned, and merged with the data from electronic medical records. All statistical analysis was performed using IBM SPSS Statistics, version 16.0 (IBM Inc, Armonk, NY). Logistic regression was used to calculate crude odds ratios (ORs) and 95% confidence intervals (CIs) for potential fall risk factors. Medications ordered for fewer than 5 cases or control patients were excluded from the analysis because of low cell counts. A multivariable model was then developed using a manual stepwise method and by inputting variables with univariate P values of less than 0.10. Abnormal gait and having a fall as the reason for admission were not included in the multivariable analysis because of collinearity with ambulation and history of falls, respectively. Patients with missing data for any of the variables included in the multivariable model were also excluded from the multivariable analysis. Variables with a P value of less than 0.05 in the multivariable analysis were retained in the final model. Two-way interaction terms for the medications included in the final model were assessed to test for effect modification. Adequacy of the model was assessed using the HosmerLemeshow goodness-of-fit test.
Additional analyses were conducted to provide further information about the medications identified as risk factors in the multivariable model. Multivariable analyses were conducted to determine whether the patients prescribed multiple high-risk medications were at greater risk for falls than others, while controlling for the patient characteristics associated with falls in the multivariable model. Fisher exact tests were used to determine whether new medication orders were associated with greater risk for falling in the hospital than medications taken before admission.
RESULTS
Fall Circumstances and Outcomes
From the 250 fall events reported during the study period, 226 first falls were identified. These cases and the corresponding 678 controls were included in the analysis. Falls were equally distributed during day (48.7%) and night (51.3%) shifts. Although most falls (81.0%) were unassisted, 14.1% of the patients who fell were assisted to the floor by an employee and 4.9% were assisted by a visitor. Common fall circumstances included falls from the bed (37.2%), falls while ambulating (23.5%), falls from a standing position (11.9%), falls from a chair (8.0%), and falls from a bedside commode (8.4%) or toilet (4.0%). Only 9.7% of the patients who fell had asked for assistance before the fall. Environmental hazards that contributed to falls included rolling equipment (7.5%), having a needed item out of reach (6.2%), inappropriate footwear (4.0%), slippery floors (3.5%), and trip hazards or clutter (1.3%). Approximately 38% of the falls were related to the patient's need for toileting.
Of the patients who fell, 161 (71.2%) were not injured. Fiftytwo patients (23.0%) sustained minor injuries, such as abrasions or bruising; 3 (1.3%) sustained moderate injury; and 3 (1.3%) sustained major injury. Moderate injuries included damaged teeth (2 patients) and facial swelling/bleeding. Major injuries included a maxillary sinus fracture, a pelvic fracture, and a subdural hematoma. The mean length of stay was similar for the patients who fell (11.3 d) and the controls (11.4 d), P = 0.903. Table 1 presents demographic, mobility, and health data for the patients who fell and the controls. Variables with univariate P values of less than 0.10 included sex, being underweight (BMI < 18.5 kg/m 2 ), history of falls during the past 3 months or as the reason for hospital admission, weak or impaired gait, needing an assistive device or person assistance to ambulate, incontinence, syncope, dizziness, overestimating ability, and providing an incorrect time estimate (confusion).
Univariate Analysis
Medication data for the case and control patients are presented in Table 2 . Medications in this table are organized according to the Cerner Multum drug classification system (www.multum.com), which is how drug order data are coded at our institution. The Multum drug classification system organizes medications into categories and subcategories by type. Certain medications, such as benzodiazepines, may be classified under different categories depending on how they are ordered, although a single medication order can have only 1 classification to avoid redundancy. The Multum system thus provides information not only about the specific drug that was ordered but also about its intended application. This allowed for a detailed analysis of the association between specific medications and medication categories and risk for falling in the hospital.
Medications associated with falling (P < 0.10) included centrally acting antiadrenergic agents (clonidine and methyldopa), benzodiazepine anticonvulsants (lorazepam, diazepam, clonazepam), hydantoin anticonvulsants (phenytoin), antidiarrheals (loperamide), insulin, tricyclic antidepressants (amitriptyline, nortriptyline, clomipramine, doxepin, desipramine), phenylpiperazine antidepressants, and haloperidol. Antiarrhythmics, potassium-sparing diuretics, vasopressors, narcotic analgesic combinations, nonsteroidal antiinflammatory drugs, 5HT3 receptor antagonists, anticholinergic antiemetics, anticholinergic antiparkinson agents, "other" anxiolytics/ sedatives (diphenhydramine and zolpidem), general anesthetics, muscle relaxants, antacids, proton pump inhibitors, antihistamines, and decongestants were associated with reduced risk.
Multivariate Analysis
The final multivariable model is presented in Table 3 . There were 887 patients included in the final model after data for 17 patients who were missing data for 1 or more of the included variables were excluded from the analysis. 
Additional Analyses
The results of the analysis to determine the effect of having orders for more than 1 of the high-risk medications identified in the multivariable model are presented in Table 4 . A doseresponse effect was observed between the number of high-risk medications and falls. The patients prescribed with 2 high-risk medications were 3.4 times more likely to fall during their hospital stay than the patients on no high-risk medications, and the patients with orders for 3 or more high-risk medications were 11.8 times more likely to fall. In the analysis to determine whether new medication orders were associated with greater risk than medications continued from home, there was no statistical difference in the proportion of new orders for cases versus controls in any of the high-risk medication categories (Fisher exact test P values: 0.48 for haloperidol; 0.61 for benzodiazepine anticonvulsants; and 1.00 for hydantoin anticonvulsants, tricyclic antidepressants, and insulin). However, this analysis may have been limited by potentially incomplete information regarding medications used before hospital admission and small numbers.
DISCUSSION
Multiple factors contribute to risk for falling in the hospital, including intrinsic patient risk factors, medications, and environmental hazards. The patient characteristics identified as risk factors in this study are generally consistent with risk factors previously identified in the literature. Female sex was associated with reduced likelihood of falls in our study, consistent with previous studies that have shown that males are at increased risk for falling in the hospital. [11] [12] [13] Prior studies have also identified history of falls, 6, 7 need for ambulatory assistance, 14, 15 confusion, 3, 7, 12, 16 dizziness, 12, 17 and incontinence 3, 12, 18 as fall risk factors. Although older age is generally considered to be an important fall risk factor, 3, 19 age was not associated with falls in our study. However, evidence for an association between older age and falls in acute care settings is inconsistent 1 and may be related to an association between age and physical changes that increase fall risk. 20 We could find no prior studies in the literature that report an association between patient BMI and risk for falling in the hospital. However, studies of community-dwelling adults have identified an association between being underweight or obese and risk for injurious falls. 21, 22 Underweight patients may be at increased risk because of frailty. 23, 24 Obese patients may be at risk if they do not exercise regularly, 15 have multiple comorbidities, 1, 15, 25 or have difficulty navigating a hospital room. Additional studies are needed to further investigate the association between BMI and fall risk.
Most of the medications identified as risk factors in this study have also been previously identified in the literature. Several studies have reported an association between anticonvulsants and risk for falling in the hospital, 6 although few have examined specific types of anticonvulsants in relation to falls. Only hydantoin and benzodiazepine anticonvulsants were identified as independent risk factors of falling in this study. Benzodiazepines are known to be associated with increased risk for falling, [26] [27] [28] and lorazepam and diazepam have been specifically identified as risk factors of falls in hospital patients 28 ; however, only 1 prior study has reported an association between hydantoins and falls. 29 Antidepressants are also known to increase the risk for falling in the hospital, 28, 30, 31 and tricyclic antidepressants have been identified as a risk factor of falls in community and nursing home settings. This study is among the first to report an association between haloperidol or insulin and falls. We could find only 1 study reporting an association between haloperidol and hospital falls, 28 although antipsychotics, in general, are a frequently identified risk factor. 31 Prior studies have reported an association between antidiabetic medications and risk for falling in the hospital but have not identified insulin, specifically, as a risk factor. 16, 27 Insulin was the only antidiabetic medication associated with falls in our study, a finding that is supported by a systematic review that found that insulin, but not other antidiabetic medications, increases fall risk. 34 Two types of medications were associated with reduced risk for falling in the multivariable model: proton pump inhibitors (esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole) and muscle relaxants (vercuronium, succinylcholine, rocuronium, cyclobenzaprine, baclofen, and atracurium). An association between proton pump inhibitors and falls has not been previously reported, and the reason for this association is unclear. An association between muscle relaxants and falls has also not been reported but is likely related to the fact that patients taking muscle relaxants are generally sedated or medically paralyzed intensive care unit patients who are relatively immobile and therefore unlikely to fall.
Although an order for a hydantoin anticonvulsant, benzodiazepine anticonvulsant, haloperidol, tricyclic antidepressant, or insulin was associated with increased risk for falling when taken alone, the risk for falling was more pronounced in the patients with orders for more than 1 of these medications. Polypharmacy, especially involving high-risk medications, has been consistently identified as a risk factor of falling in the hospital. 6, 9 These findings suggest that patients with orders for multiple high-risk medications should be placed on fall precautions and that alternative medication regimens should be considered, when possible. Although we found no statistical difference in the proportion of new medication orders for the patients who fell versus the controls, further study is warranted because small numbers and potentially incomplete home medication records may have limited this analysis.
Strengths of this study include prospective data collection, detailed evaluation of medications, use of multivariable analysis, and a relatively large sample size. Limitations include the matching of cases and controls only on date of admission and data limitations, including inconsistencies in fall risk assessments, fall reports completed by staff who may not have witnessed the fall, and medication data derived from pharmacy orders rather than drug administration records. As a single-institution study, our results may also not be broadly generalizable. Additional studies that make use of more robust data and statistical techniques will be needed to validate the associations identified in this study and to evaluate the impact of patient diagnosis and comorbidity on these associations. Additional research is also needed to identify risk factors of falls in groups excluded in this analysis, such as oncology and psychiatry patients. Large multicenter data sets will be needed to examine infrequently prescribed medications and allow for greater generalizability of study results.
CONCLUSIONS
This study identified medications and patient characteristics associated with falls in a hospital setting and examined the impact of multiple high-risk medications on risk for falling. The results provide further evidence for an association between certain medications and risk for falling in the hospital, with risk being more pronounced in patients prescribed with more than 1 high-risk medication. Supplementing existing fall risk assessment and prevention tools with medication review targeting these high-risk medications may allow for better identification of patients at risk for falling during their hospital admission and help to reduce the incidence of patient falls. High-risk medications should be avoided, when possible, especially for patients who are already at high risk for falls or injury. The accumulating evidence for an association between certain medications and risk for falling, and the importance of falls as a public health and hospital safety problem, also suggests that it may be beneficial to routinely evaluate the potential effect of new medications on fall risk during the drug approval process.
